Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy

BACKGROUND: Persistent inflammation on histology after successful hepatitis C (HCV) treatment has been reported. However, data regarding the long-term impact in liver transplant recipients is limited, particularly after using direct-acting antiviral (DAA) therapies. AIM: To evaluate the impact of su...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismail, Bahaaeldeen, Benrajab, Karim M, Bejarano, Pablo, Ruiz, Phillip, Sears, Debbie, Tzakis, Andreas, Zervos, Xaralambos Bobby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055203/
https://www.ncbi.nlm.nih.gov/pubmed/35582292
http://dx.doi.org/10.4254/wjh.v14.i3.602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055203/
https://www.ncbi.nlm.nih.gov/pubmed/35582292
http://dx.doi.org/10.4254/wjh.v14.i3.602

Ejemplares similares